Plain-English translation of NCT06940323 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Multiple Sclerosis research guide →This is a registry study that collects blood samples and health information from pregnant women who have chronic neurological or inflammatory conditions, as well as healthy pregnant women. Researchers will track how pregnancy progresses, how the baby develops after birth, and analyze the blood samples to better understand how chronic conditions affect mothers and infants. The goal is to build a resource that helps doctors understand pregnancy outcomes for women living with these conditions.
Very little is known about how chronic conditions like multiple sclerosis, myasthenia gravis, and others affect pregnancy, baby health, and breastfeeding. By collecting information and samples from women during and after pregnancy, researchers hope to better understand the risks and protections, and eventually improve care for both mothers and babies.
You likely qualify if…
You likely don't qualify if…
You will have visits during pregnancy planning (if applicable), at baseline, around 36 weeks of pregnancy, and at 1, 4, 8, and 12 months after delivery. At these visits, you'll give blood samples and answer questions about your health, mood, disease activity, and social support through surveys and interviews. Researchers will also review your medical records to track your condition and your baby's growth and development. If you breastfeed, you may provide additional samples. Overall, participation spans roughly one year from pregnancy planning through one year postpartum.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
United States